Pharmadrug Inc. (CSE:PHRX)
Canada · Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
Jun 18, 2026, 10:17 AM EST
Pharmadrug Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -0.47 | -0.38 | -0.79 | -13.2 | -8.88 | -5.63 |
Depreciation & Amortization | 0.05 | 0.05 | 0.05 | 0.03 | 0.02 | 0.02 |
Other Amortization | - | - | - | 0.04 | 0.03 | - |
Asset Writedown & Restructuring Costs | - | - | - | 10.14 | - | - |
Loss (Gain) From Sale of Investments | - | - | 0.01 | 0.05 | 0.61 | 0.72 |
Loss (Gain) on Equity Investments | 0.06 | - | - | - | - | - |
Stock-Based Compensation | - | - | 0.05 | 1.74 | 0.34 | 0.6 |
Other Operating Activities | 0.19 | 0.14 | 0.23 | 0.23 | 5.8 | 1.46 |
Change in Accounts Receivable | -0.01 | 0.01 | -0 | 0 | -0.06 | 0.06 |
Change in Inventory | - | - | - | - | 0.07 | 0 |
Change in Accounts Payable | 0.04 | 0.08 | -0.29 | 0.35 | 0.57 | -0.18 |
Change in Other Net Operating Assets | 0.01 | 0.01 | -0.01 | -0.06 | 0.1 | -0.02 |
Operating Cash Flow | -0.14 | -0.09 | -0.76 | -0.67 | -2.26 | -4.13 |
Cash Acquisitions | - | - | - | 0.74 | - | 0.31 |
Divestitures | - | - | - | - | -0.01 | - |
Sale (Purchase) of Intangibles | - | - | -0.01 | - | - | - |
Investment in Securities | - | - | - | 0.25 | 0.09 | 1.21 |
Other Investing Activities | - | - | - | - | -0 | -0.04 |
Investing Cash Flow | - | - | -0.01 | 1 | 0.08 | 1.48 |
Long-Term Debt Issued | - | - | - | 0.1 | 0.65 | - |
Total Debt Issued | 0.09 | - | - | 0.1 | 0.65 | - |
Long-Term Debt Repaid | - | - | - | -0.1 | -0.05 | - |
Total Debt Repaid | - | - | - | -0.1 | -0.05 | - |
Net Debt Issued (Repaid) | 0.09 | - | - | 0 | 0.6 | - |
Issuance of Common Stock | - | - | 0.23 | - | 0.27 | 0.95 |
Other Financing Activities | - | - | 0.09 | 0.22 | -0.03 | -0.18 |
Financing Cash Flow | 0.09 | - | 0.32 | 0.23 | 0.84 | 0.78 |
Foreign Exchange Rate Adjustments | - | - | -0 | 0 | 0.39 | 0.69 |
Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - | - |
Net Cash Flow | -0.04 | -0.09 | -0.45 | 0.55 | -0.95 | -1.18 |
Free Cash Flow | -0.14 | -0.09 | -0.76 | -0.67 | -2.26 | -4.13 |
Free Cash Flow Margin | - | - | - | - | - | -58906.35% |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.04 | -0.09 |
Cash Interest Paid | - | - | - | 0.08 | 0.04 | 0.11 |
Levered Free Cash Flow | -0.54 | -0.43 | -0.63 | 1.71 | -1.59 | -1.26 |
Unlevered Free Cash Flow | -0.32 | -0.24 | -0.5 | 1.88 | -1.48 | -1.23 |
Change in Working Capital | 0.04 | 0.1 | -0.3 | 0.29 | 0.69 | -0.13 |